DC Circ. Defers To FDA In Stem Cell Device Marketing Row
The D.C. Circuit on Friday backed the U.S. Food and Drug Administration's denial of expedited marketing approval for two Cytori Therapeutics Inc. devices that harvest stem cells from fat tissue, saying...To view the full article, register now.
Already a subscriber? Click here to view full article